Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...
Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...
Authored by Mike Khor
In October, I had the privilege to represent Culture Biosciences at the...
Cell line screening and development plays a fundamental role in the biopharmaceutical industry,...
Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...
Modeling and simulation can be a powerful tool for bioprocess design. We now present InSiliCHO, an...
A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...
As we launch our 5L bioreactors, our co-founder and CEO Will Patrick reflects on why this is such a...
revised December 15, 2022
How empowering cell line engineering groups with Culture's cloud...
The recent increase in consumer demand for sustainably made products has led to a surge in the...
Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...
What could you achieve with more bioreactor capacity?
You’re no longer limited by the bioreactor capacity in your lab.
© Culture Biosciences. All rights reserved.